FinTrust Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $33.3K | Buy |
64
+2
| +3% | +$1.04K | 0.01% | 691 |
|
|
2024
Q2 | $33.6K | Buy |
62
+20
| +48% | +$10.8K | 0.01% | 635 |
|
|
2024
Q1 | $21.8K | Buy |
42
+2
| +5% | +$1.04K | ﹤0.01% | 701 |
|
|
2023
Q4 | $18.9K | Hold |
40
| – | – | ﹤0.01% | 686 |
|
|
2023
Q3 | $17.4K | Buy |
40
+5
| +14% | +$2.18K | ﹤0.01% | 678 |
|
|
2023
Q2 | $18K | Hold |
35
| – | – | ﹤0.01% | 668 |
|
|
2023
Q1 | $18K | Hold |
35
| – | – | ﹤0.01% | 667 |
|
|
2022
Q4 | $18K | Hold |
35
| – | – | ﹤0.01% | 666 |
|
|
2022
Q3 | $17K | Buy |
35
+8
| +30% | +$3.89K | ﹤0.01% | 752 |
|
|
2022
Q2 | $12K | Sell |
27
-12
| -31% | -$5.33K | ﹤0.01% | 834 |
|
|
2022
Q1 | $19K | Hold |
39
| – | – | ﹤0.01% | 770 |
|
|
2021
Q4 | $18K | Buy |
+39
| New | +$18K | ﹤0.01% | 762 |
|
|
2020
Q3 | – | Sell |
-60
| Closed | -$16K | – | 1142 |
|
|
2020
Q2 | $16K | Sell |
60
-125
| -68% | -$33.3K | 0.01% | 656 |
|
|
2020
Q1 | $42K | Sell |
185
-64
| -26% | -$14.5K | 0.02% | 469 |
|
|
2019
Q4 | $75K | Buy |
249
+14
| +6% | +$4.22K | 0.03% | 367 |
|
|
2019
Q3 | $56K | Sell |
235
-16
| -6% | -$3.81K | 0.02% | 404 |
|
|
2019
Q2 | $71K | Buy |
251
+81
| +48% | +$22.9K | 0.03% | 339 |
|
|
2019
Q1 | $49K | Buy |
170
+62
| +57% | +$17.9K | 0.02% | 394 |
|
|
2018
Q4 | $28K | Buy |
+108
| New | +$28K | 0.01% | 498 |
|